BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 18793669)

  • 1. Regulation of chemokine activity by posttranslational modification.
    Mortier A; Van Damme J; Proost P
    Pharmacol Ther; 2008 Nov; 120(2):197-217. PubMed ID: 18793669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCR1- and CCR5-mediated inactivation of leukocytes by a nonglycosaminoglycan (non-GAG)-binding variant of n-nonanoyl-CCL14 (NNY-CCL14).
    Gupta S; Rieder S; Richter R; Schulz-Maronde S; Manns J; Escher SE; Heitland A; Mack M; Forssmann WG; Elsner J; Forssmann U
    J Leukoc Biol; 2010 Aug; 88(2):383-92. PubMed ID: 20483925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the mechanisms regulating chemokine activity and availability.
    Mortier A; Van Damme J; Proost P
    Immunol Lett; 2012 Jul; 145(1-2):2-9. PubMed ID: 22698177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of posttranslational processing on the in vitro and in vivo activity of chemokines.
    Mortier A; Gouwy M; Van Damme J; Proost P
    Exp Cell Res; 2011 Mar; 317(5):642-54. PubMed ID: 21146523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxyl terminus of the chemokine receptor CCR3 contains distinct domains which regulate chemotactic signaling and receptor down-regulation in a ligand-dependent manner.
    Sabroe I; Jorritsma A; Stubbs VE; Xanthou G; Jopling LA; Ponath PD; Williams TJ; Murphy PM; Pease JE
    Eur J Immunol; 2005 Apr; 35(4):1301-10. PubMed ID: 15739168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine-protease interactions in cancer.
    Van Damme J; Struyf S; Opdenakker G
    Semin Cancer Biol; 2004 Jun; 14(3):201-8. PubMed ID: 15246056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allergy-associated chemokine receptors CCR3 and CCR5 can be inactivated by the modified chemokine NNY-CCL11.
    Manns J; Rieder S; Escher S; Eilers B; Forssmann WG; Elsner J; Forssmann U
    Allergy; 2007 Jan; 62(1):17-24. PubMed ID: 17156337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-translational control of chemokines: a role for decoy receptors?
    Comerford I; Nibbs RJ
    Immunol Lett; 2005 Jan; 96(2):163-74. PubMed ID: 15585320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemokines, CX3CL1, CCL14, and CCL4, promote human trophoblast migration at the feto-maternal interface.
    Hannan NJ; Jones RL; White CA; Salamonsen LA
    Biol Reprod; 2006 May; 74(5):896-904. PubMed ID: 16452465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13.
    Stich S; Loch A; Leinhase I; Neumann K; Kaps C; Sittinger M; Ringe J
    Eur J Cell Biol; 2008 Jun; 87(6):365-76. PubMed ID: 18501472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of N-terminal proteolysis of CCL14a to activity on the chemokine receptors CCR1 and CCR5 and the human cytomegalovirus-encoded chemokine receptor US28.
    Richter R; Casarosa P; Ständker L; Münch J; Springael JY; Nijmeijer S; Forssmann WG; Vischer HF; Vakili J; Detheux M; Parmentier M; Leurs R; Smit MJ
    J Immunol; 2009 Jul; 183(2):1229-37. PubMed ID: 19553544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and functional characterization of CC chemokine CCL14.
    Blain KY; Kwiatkowski W; Zhao Q; La Fleur D; Naik C; Chun TW; Tsareva T; Kanakaraj P; Laird MW; Shah R; George L; Sanyal I; Moore PA; Demeler B; Choe S
    Biochemistry; 2007 Sep; 46(35):10008-15. PubMed ID: 17691823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic chemokines directly labeled with a fluorescent dye as tools for studying chemokine and chemokine receptor interactions.
    Strong AE; Thierry AC; Cousin P; Moulon C; Demotz S
    Eur Cytokine Netw; 2006 Mar; 17(1):49-59. PubMed ID: 16613763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus.
    Alcamí A; Symons JA; Collins PD; Williams TJ; Smith GL
    J Immunol; 1998 Jan; 160(2):624-33. PubMed ID: 9551896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine-binding specificity of soluble chemokine-receptor analogues: identification of interacting elements by chimera complementation.
    Datta-Mannan A; Stone MJ
    Biochemistry; 2004 Nov; 43(46):14602-11. PubMed ID: 15544331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CC and CXC chemokines in human antigen-presenting dendritic cells by the pneumococcal proteins pneumolysin and CbpA, and the role played by toll-like receptor 4, NF-kappaB, and mitogen-activated protein kinases.
    Bernatoniene J; Zhang Q; Dogan S; Mitchell TJ; Paton JC; Finn A
    J Infect Dis; 2008 Dec; 198(12):1823-33. PubMed ID: 18945182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine scanning mutagenesis of the chemokine receptor CCR3 reveals distinct extracellular residues involved in recognition of the eotaxin family of chemokines.
    Duchesnes CE; Murphy PM; Williams TJ; Pease JE
    Mol Immunol; 2006 Mar; 43(8):1221-31. PubMed ID: 16102831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural post-translational modifications of chemokines.
    Proost P; Struyf S; Van Damme J
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):997-1001. PubMed ID: 17073736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chapter 1. Isolation, identification, and production of posttranslationally modified chemokines.
    Loos T; Mortier A; Proost P
    Methods Enzymol; 2009; 461():3-29. PubMed ID: 19480912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic processing of chemokines: implications in physiological and pathological conditions.
    Wolf M; Albrecht S; Märki C
    Int J Biochem Cell Biol; 2008; 40(6-7):1185-98. PubMed ID: 18243768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.